An introduction to the what, the why, the how, and the current and future impact of the Falsified Medicines Directive (EUFMD) on you and your supply chain partners. Discover more about the threat to patient safety, the obligations placed on stakeholders, and the industry’s response. Presented by Ian Haynes at 3C Excellis Europe.